METHODS: Participants (clinicians, practice guideline developers/researchers, and policymakers) will be randomly assigned to one of three groups: 1) Tutorial Only Intervention: participants will review the online overview tutorial of the AGREE II with a virtual coach. 2) Tutorial plus Practice Exercise Intervention: participants will receive the same online overview tutorial of the AGREE II but will also receive a training practice guideline to appraise. The training practice guideline exercise will provide participants with immediate feedback on how their scores compare to expert norms. 3) Control Group: participants will review the PDF version of the AGREE II. All participants will review and assess a test practice guideline with the AGREE II following their assigned interventions. RESULTS: Compare learner's performance, satisfaction, self-efficacy, mental effort, and time-on-task across the three groups.
DISCUSSION (CONCLUSION):
Our research will test innovative computer-based educational interventions to promote the successful and accurate application of AGREE II and will identify strategies that are most effective. Results will facilitate international capacity to apply AGREE II with confidence and to enhance the overall guideline enterprise. The study launch date is February 2010. TARGET AUDIENCE(S): 1. Users of the AGREE II Instrument 2. Guideline developer 3. Guideline implementer 4. Developer of guideline-based products 5. Quality improvement manager/facilitator 6. Medical educator S114-Synthesizing guideline recommendations for practice: Pre-conception care for women with diabetes as a case study Danielle Mazza, MBBS (Presenter) (Monash University, Notting Hill Melbourne, Victoria, Australia); Maimunah Mahmud (Monash University, Notting Hill, Victoria, Australia)
PRIMARY TRACK: Guideline implementation SECONDARY TRACK: Other guideline implementation BACKGROUND (INTRODUCTION):
The prevalence of type 2 diabetes mellitus (T2DM) continues to rise worldwide. More women from developing countries who are in the reproductive age group have diabetes, resulting in more pregnancies complicated by T2DM and placing both mother and fetus at higher risk. We aimed to compare the quality and content of current guidelines concerned with the pre-conception care of women with diabetes and to develop a summary of recommendations to assist in the management of diabetic women contemplating pregnancy.
LEARNING OBJECTIVES (TRAINING GOALS):
1. Compare and contrast international guidelines concerning the pre-conception care of women with diabetes.
2. Summarize guideline recommendations for the pre-conception care of women with diabetes. METHODS: Relevant clinical guidelines were identified through a search of databases (MEDLINE, SCOPUS, and The Cochrane Library) and relevant websites. Five guidelines were identified. Each guideline was assessed for quality using the AGREE instrument. Guideline recommendations were extracted, compared, and contrasted. RESULTS: All guidelines were assessed as being of high quality and strongly recommended for use in practice. All were consistent in counseling about the risk of congenital malformation related to uncontrolled blood sugar pre-conceptionally, ensuring adequate contraception until glycemic control is achieved, use of HBA1C to monitor metabolic control, when to commence insulin, and switching from ACE inhibitors to other antihypertensives. Major differences were in the targets recommended for optimal metabolic control and opinion regarding the usage of metformin as an adjunct or alternative treatment before or during pregnancy.
DISCUSSION (CONCLUSION):
International guidelines for the care of women with diabetes who are contemplating pregnancy are consistent in their recommendations; however, some are more comprehensive than others. Having established current standards for the pre-conception care of diabetic women, there is now a need to focus on guideline implementation through an examination of the barriers and enablers to successful implementation and the applicability of the recommendations in the local setting. TARGET AUDIENCE(S): 1. Clinical researcher 2. Evidence synthesizer, developer of systematic reviews or meta-analyses 3. Guideline developer 4. Developer of guideline-based products 5. Medical educator 6. Consumers' and patients' representatives S115-The map of medicine's editorial methodology: How we use CPGs to make our care pathways Gajan Srikanthan, MBBS (Presenter) (Map of Medicine, London, England, United Kingdom)
PRIMARY TRACK: Guideline implementation SECONDARY TRACK: Other guideline implementation BACKGROUND (INTRODUCTION):
The Map of Medicine produces care pathways using its editorial methodology. Our approach to evidence-based literature, practice-based knowledge, and pathway updating is crucial.
LEARNING OBJECTIVES (TRAINING GOALS):
1. Clinical practice guidelines (CPGs) form the backbone of our pathways. 2. Possible CPGs for inclusion are identified by searching 130ϩ grey (non-indexed) literature producers. METHODS: For a CPG to be incorporated, its development process needs to demonstrate a rigorous methodology, editorial independence, and appropriate representation of patient and clinical groups. The Map uses the AGREE instrument to appraise and select quality CPGs. A further appraisal process allows us to rank CPGs into a hierarchy, enabling resolution of clinical conflicts. Recommendations on a clinical topic may vary between CPGs, indicating heterogeneity within the evidence or lack of clinical consensus. The Map does not attempt to define best practice by excluding certain recommendations and including others; instead, we acknowledge the existence of ambiguity by stating all viewpoints. The order in which differing recommendations are displayed is guided by their position in the hierarchy. RESULTS: The Map searches and appraises secondary literature to identify those articles published since the date of search employed in the highest-ranked CPG. The findings of these articles are incorporated.
DISCUSSION (CONCLUSION):
Practice-based information is incorporated by assembling an expert group to advise on the pathway's flow and content, adding knowledge where gaps are present. Contributions by experts are referenced as such. Pathways created with contributors representing Royal Colleges or clinical societies receive accreditation by that organization. The Map also has a Board of Fellows, a group of clinicians who provide input during drafting. Following publication, indexed and grey literature searches continue twomonthly. New literature is assessed for importance and pathways are changed as required. TARGET AUDIENCE(S): 1. Clinical researcher 2. Evidence synthesizer, developer of systematic reviews or meta-analyses 3. Guideline developer 4. Guideline implementer 5. Developer of guideline-based products 6. Quality improvement manager/facilitator 7. Medical educator 8. Health care policy analyst/policymaker 9. Health insurance payers and purchasers 10. Medical providers and executives 11. Allied health professionals 12. Consumers' and patients' representatives 13. Nurses S116-Comparison of different methods when aggregating quality indicators issued from guidelines in acute myocardial infarction Mé lanie Couralet (HAS/COMPAQH project, Villejuif, France,); Sophie Guerin (Presenter) (COMPAQH project, Villejuif, France); Marc Le Vaillant (CERMES, Villejuif, France); Philippe Loirat (COMPAQH project, Villejuif, France); Christine Gardel (HAS, Saint-Denis La Plaine, France); Etienne Minvielle (COMPAQH project, Villejuif, France) PRIMARY TRACK: Guideline implementation
